Triple vs. Dual Therapy with Low-Dose Dapagliflozin plus Saxagliptin vs. Each Monocomponent Added to Metformin in Uncontrolled Type 2 Diabetes

JULIO ROSENSTOCK; SHIRA PERL; EVA K. JOHNSSON; STEPHAN JACOB

doi:10.2337/db18-1149-p

Triple vs. Dual Therapy with Low-Dose Dapagliflozin plus Saxagliptin vs. Each Monocomponent Added to Metformin in Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db18-1149-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1149-P

Author(s):

JULIO ROSENSTOCK ◽

SHIRA PERL ◽

EVA K. JOHNSSON ◽

STEPHAN JACOB

Keyword(s):

Type 2 Diabetes ◽

Low Dose ◽

Dual Therapy

Download Full-text

Author response for "Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes"

10.1111/dom.13795/v2/response1 ◽

2019 ◽

Author(s):

Julio Rosenstock ◽

Shira Perl ◽

Eva Johnsson ◽

Ricardo García‐Sánchez ◽

Stephan Jacob

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy ◽

Author Response

Download Full-text

Review for "Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes"

10.1111/dom.13795/v1/review2 ◽

2019 ◽

Author(s):

James Boyle

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy

Download Full-text

Review for "Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes"

10.1111/dom.13795/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy

Download Full-text

Triple therapy with low‐dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.13795 ◽

2019 ◽

Vol 21 (9) ◽

pp. 2152-2162 ◽

Cited By ~ 6

Author(s):

Julio Rosenstock ◽

Shira Perl ◽

Eva Johnsson ◽

Ricardo García‐Sánchez ◽

Stephan Jacob

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy

Download Full-text

Review for "Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes"

10.1111/dom.13795/v2/review2 ◽

2019 ◽

Author(s):

James Boyle

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy

Download Full-text

Decision letter for "Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes"

10.1111/dom.13795/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy

Download Full-text

Review for "Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes"

10.1111/dom.13795/v1/review3 ◽

2019 ◽

Author(s):

Stefano Del Prato

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy

Download Full-text

Review for "Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes"

10.1111/dom.13795/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy

Download Full-text

Decision letter for "Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes"

10.1111/dom.13795/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Triple Therapy ◽

Low Dose ◽

Dual Therapy

Download Full-text

Faculty Opinions recommendation of Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058971.510928 ◽

2007 ◽

Author(s):

Henry Burger

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Hormone Replacement Therapy ◽

Replacement Therapy ◽

Glucose Homeostasis ◽

Low Dose ◽

Hormone Replacement

Download Full-text